Boundless Bio Common Stock Market Value
| BOLD Stock | USD 1.16 0.03 2.65% |
| Symbol | Boundless |
Will Biotechnology sector continue expanding? Could Boundless diversify its offerings? Factors like these will boost the valuation of Boundless Bio. Projected growth potential of Boundless fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Boundless Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Boundless Bio Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio's value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Boundless Bio's market value can be influenced by many factors that don't directly affect Boundless Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Boundless Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Boundless Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Boundless Bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Boundless Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Boundless Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Boundless Bio.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Boundless Bio on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Boundless Bio Common or generate 0.0% return on investment in Boundless Bio over 90 days. Boundless Bio is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, and Lipocine. Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene ther... More
Boundless Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Boundless Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Boundless Bio Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 16.75 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 4.24 |
Boundless Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Boundless Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Boundless Bio's standard deviation. In reality, there are many statistical measures that can use Boundless Bio historical prices to predict the future Boundless Bio's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.35) | |||
| Treynor Ratio | (0.24) |
Boundless Bio February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.23) | |||
| Mean Deviation | 2.14 | |||
| Coefficient Of Variation | (3,474) | |||
| Standard Deviation | 2.97 | |||
| Variance | 8.83 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.35) | |||
| Treynor Ratio | (0.24) | |||
| Maximum Drawdown | 16.75 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 4.24 | |||
| Skewness | 0.9166 | |||
| Kurtosis | 2.58 |
Boundless Bio Common Backtested Returns
Boundless Bio Common secures Sharpe Ratio (or Efficiency) of -0.0104, which signifies that the company had a -0.0104 % return per unit of risk over the last 3 months. Boundless Bio Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Boundless Bio's Risk Adjusted Performance of (0.02), standard deviation of 2.97, and Mean Deviation of 2.14 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.39, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Boundless Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Boundless Bio is expected to be smaller as well. At this point, Boundless Bio Common has a negative expected return of -0.0304%. Please make sure to confirm Boundless Bio's day median price, price action indicator, as well as the relationship between the accumulation distribution and potential upside , to decide if Boundless Bio Common performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.74 |
Almost perfect reverse predictability
Boundless Bio Common has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Boundless Bio time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Boundless Bio Common price movement. The serial correlation of -0.74 indicates that around 74.0% of current Boundless Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.74 | |
| Spearman Rank Test | -0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Boundless Bio Common is a strong investment it is important to analyze Boundless Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Boundless Bio's future performance. For an informed investment choice regarding Boundless Stock, refer to the following important reports:Check out Boundless Bio Correlation, Boundless Bio Volatility and Boundless Bio Performance module to complement your research on Boundless Bio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Boundless Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.